Physician profile
John M Baga
NPI 1407090921
$8,569.45
in general payments reported to CMS, 2019-2025
39 companies · $2,274 in 2025
The $2,274 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,345 · 2020: $338 · 2021: $51.89 · 2022: $420 · 2023: $1,427 · 2024: $2,713 · 2025: $2,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,414.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,212.49 | 2019-2025 | |
| Abbvie INC. | $1,141.29 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Lilly USA, LLC | $1,098.71 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $897.10 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $676.57 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $561.29 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $489.88 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $441.27 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $280.56 | 2024-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $247.01 | 2019-2025 | Jardiance, Synjardy |
| Astellas Pharma US INC | $219.90 | 2020-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $215.16 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $200.70 | 2019-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Amarin Pharma, INC. | $64.72 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.16 | 2019-2024 | Trintellix |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.